follow your trial team's hypoglycaemia management plan Severe or persistent changes in mood, or any thoughts of self-harm or suicide whilst a causal link between GLP-1-based medicines and mood changes has not been established (regulatory reviews, including by the EMA, are ongoing), any significant psychological symptoms should be reported promptly [13] [14] Any allergic reaction, including rash or skin changes It is also important to report any new or worsening symptoms to your trial team, even if they seem minor
FDA removed tirzepatide injection from the shortage list on October 2, 2024, later reevaluated that decision, and then confirmed in December 2024 that the shortage was resolved
Studies show steel-cut oats have a glycemic index of 55, producing glucose peak rises of only 1.93 mmol/L compared to 2.47 mmol/L for instant varieties
GLP-1 Receptor Activation and Epac2 Link Atrial Natriuretic Peptide Secretion to Control of Blood Pressure
Why peptides degrade in the first place is something we cover separately in the article on the chemistry behind peptide degradation
Your mobility might improve before you see tissue changes